Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 11, 2004, Pages 1505-1511

  Lazzeri, Elena ^a   Pauwels, Ernest K J ^b   Erba, Paola A ^a   Volterrani, Duccio ^a   Manca, Mario ^a,f   Bodei, Lisa ^c   Trippi, Donatella ^a   Bottoni, Antonio ^a   Cristofani, Renza ^a,d   Consoli, Vincenzo ^a   Palestro, Christopher J ^e   Mariani, Giuliano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^f Town Hospital   (Italy)

Author keywords

Diagnostic performance; Imaging modalities; Two step streptavidin 111In biotin scintigraphy; Vertebral osteomyelitis

Indexed keywords

PENTETATE INDIUM IN 111; STREPTAVIDIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FEMALE; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SAMPLE SIZE; SPINE SCINTISCANNING; SPONDYLITIS;

ADULT; AGED; AGED, 80 AND OVER; BIOTIN; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOMYELITIS; PENTETIC ACID; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPINE; SPONDYLITIS;

EID: 9944241382     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1581-2     Document Type: Article

References (47)

1. Eismont FJ, Bohlman HH, Soni PL, Goldberg VM, Freeafer AA. Pyogenic and fungal vertebral osteomyelitis with paralysis. J Bone Joint Surg 1983;65A:19-29
2. Enzmann DR. Infection and inflammation. In: Enzmann DR, DeLaPaz RL, Rubin JB, eds. Magnetic resonance of the spine. St. Louis: Mosby; 1990:260-300
3. Wolansky LJ, Heary RF, Patterson T, Friedenberg JS, Tholany J, Chen JK, Patel N, Doddakashi S. Pseudosparing of the endplate: a potential pitfall in using MR imaging to diagnose infectious spondylitis. AJR 1999;172:777-780
4. Wagner SC, Schweitzer ME, Morrison WB, Przybylski GJ, Parker L. Can imaging findings help differentiate spinal neuropathic arthropathy from disk space infection? Initial experience. Radiology 2000;214:693-699
5. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am 1997;79:874-880
6. McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis 2002;34:1342-1350
7. Handmaker H, Leonards R. The bone scan in inflammatory osseous disease. Semin Nucl Med 1976;6:95-105
8. Maurer AH, Chen DCP, Camargo EE, Wong DF, Wagner HN Jr, Alderson PO. Utility of three-phase skeletal scintigraphy in suspected osteomyelitis: concise communication. J Nucl Med 1981;22:941-949
9. 99mTc-labelled nano-colloid. Arch Orthop Trauma Surg 1990;110:26-32
10. Hotze AL, Briele B, Overbeck B, Kropp J, Gruenwald F, Mekkawy MA, von Smekal A, Moeller F, Biersack HJ. Technetium-99m-labeled anti-granulocyte antibodies in suspected bone infections. J Nucl Med 1992;33:526-531
11. Gratz S, Braun HG, Behr TM, Meller J, Herrmann A, Conrad M, Rathmann D, Bertagnoli R, Willert HG, Becker W. Photopenia in chronic vertebral osteomyelitis with technetium-99m-antigranulocyte antibody (BW 250/183). J Nucl Med 1997;38:211-216
12. Boerman OC, Rennen H, Oyen WJ, Corstens FH. Radiopharmaceuticals to image infection and inflammation. Semin Nucl Med 2000;31:286-295
13. Turpin S, Lambert R. Role of scintigraphy in musculoskeletal and spinal infections. Radiol Clin North Am 2001;39:169-189
14. 99mTc-labelled peptide-based radiopharmaceuticals: an overview. Nucl Med Commun 1999;20:1093-1112
15. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 2000;27:292-301
16. Kalicke T, Schmitz A, Risse JH, Arens S, Keller E, Hansis M, Schmitt O, Biersack HJ, Grunwald F. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000;27:524-528
17. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27:822-832
18. Rennen HJ, Corstens FH, Oyen WJ, Boerman OC. New concepts in infection/inflammation imaging. Q J Nucl Med 2001;45:167-173
19. Signore A, Annovazzi A, Chianelli M, Corsetti F, Van de Wiele C, Waterhouse RN. Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 2001;28:1555-1565
20. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002;32:47-59
21. Devillers A, Moisan A, Jean S, Arvieux C, Bourguet P. Technetium-99m hexamethyl-propylene amine oxime leucocyte scintigraphy for the diagnosis of bone and joint infections: a retrospective study in 116 patients. Eur J Nucl Med 1995;22:302-307
22. Palestre CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997;27:334-345
23. Coleman RE, Welch D. Possible pitfalls with clinical imaging of indium-111 leukocytes. J Nucl Med 1980;21:122-125
24. Mok YP, Carney WH, Fernandez-Ulloa M. Skeletal photopenic lesions in In-111 WBC imaging. J Nucl Med 1984;25:1322-1326
25. Fernandex-Ulloa M, Vasavada PJ, Hanslits ML, Volarich DT, Elgazzar AH. Diagnosis of vertebral osteomyelitis: clinical, radiological and scintigraphic features. Orthopedics 1985;8:1144-1150
26. Datz FL, Thorne DA. Cause and significance of cold bone defects on indium-111-labeled leukocyte imaging. J Nucl Med 1987;28:820-823
27. Palestro CJ, Kim CK, Swyer AJ, Vallabhajosula S, Goldsmith SJ. Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J Nucl Med 1991;32:1861-1865
28. Whalen JL, Brown ML, McLeod R, Fitzgerald RH Jr. Limitations of indium leukocyte imaging for the diagnosis of spine infections. Spine 1991;16:193-197
29. Jacobson AF, Gilles CP, Cerqueira MD. Photopenic defects in marrow-containing skeleton on indium-111 leucocyte scintigraphy: prevalence at sites suspected of osteomyelitis and as an incidental finding. Eur J Nucl Med 1992;19:858-864
30. Even-Sapir E, Martin RH. Degenerative disc disease. A cause for diagnostic dilemma on In-111 WBC studies in suspected osteomyelitis. Clin Nucl Med 1994;19:388-392
31. 111In-white blood cell scintigraphy. Semin Nucl Med 2002;32:236-237
32. 99mTc-MDP for estimating the severity of vertebral osteomyelitis. Nucl Med Commun 2000;21:111-120
33. Love C, Patel M, Lonner BS, Tomas MB, Palestra CJ. Diagnosing spinal osteomyelitis: a comparison of bone and Ga-67 scintigraphy and magnetic resonance imaging. Clin Nucl Med 2000;25:963-977
34. Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med 1992;33:1810-1815
35. 111In-labelled biotin scan: a new radioisotopic method for localising vascular graft infections. Eur J Endovasc Surg 1995;10:405-414
36. Rusckowski M, Paganelli G, Hnatowich DJ, Magnani P, Virzi F, Fogarasi M, DiLeo C, Sudati F, Fazio F. Imaging osteomyelitis with streptavidin and indium-111-labeled biotin. J Nucl Med 1996;37:1655-1662
37. Lazzeri E, Manca M, Molea N, Marchetti S, Consoli V, Bodei L, Bianchi R, Chinol M, Paganelli G, Mariani G. Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patients. Eur J Nucl Med 1999;26:606-614
38. Attwood PV. The structure and the mechanism of action of pyruvate carboxylase. Int J Biochem Cell Biol 1995;27:231-249
39. Carragee EJ, Kim D, van der Vlugt T, Vittum D. The clinical use of erythrocyte sedimentation rate in pyogenic vertebral osteomyelitis. Spine 1997;22:2089-2093
40. Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956
41. Aliabadi P, Nikpoor N. Imaging osteomyelitis. Arthritis Rheum 1994;37:617-622
42. Wagner SC, Schwitzer ME, Morrison WB, Przybylski GJ, Parker L. Can imaging findings help differentiate spinal neuropathic arthropathy from disk space infection? Initial experience. Radiology 2000;214:693-699
43. Rothman SL. The diagnosis of infections of the spine by modern imaging techniques. Orthop Clin North Am 1996; 27:15-31
44. Samuel A, Paganelli G, Chiesa R, Sudati F, Calvitto M, Melissano G, Grossi A, Fazio F. Detection of prosthetic vascular graft infection using avidin/indium-111-biotin scintigraphy. J Nucl Med 1996;37:55-61
45. Chinol M, Casalini P, Maggiolo M, Canevari S, Omodeo ES, Caliceti P, Veronese FM, Cremonesi M, Chiolerio F, Nardone E, Siccardi AG, Paganelli G. Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. Br J Cancer 1998;78:189-197
46. Caliceti P, Chinol M, Roldo M, Veronese FM, Semenzato A, Salmaso S, Paganelli G. Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargeting. J Control Rel 2002;83:97-108
47. 90Y- biotin: dosimetry and pharmacokinetics in cancer patients. Eur J Nucl Med 1999;26:110-120